Best Practices in Cardiac Care: Getting with the Guidelines

Similar documents
Treating Hypertension in 2018: What Makes the Most Sense Today?

New Recommendations for the Treatment of Hypertension: From Population Salt Reduction to Personalized Treatment Targets

Combination Therapy for Hypertension

HYPERTENSION GUIDELINES WHERE ARE WE IN 2014

Monthly Campaign Webinar. April 21, 2016

The Latest Generation of Clinical

DISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose.

Management of Lipid Disorders and Hypertension: Implications of the New Guidelines

JNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults

Hypertension and the SPRINT Trial: Is Lower Better

Hypertension Guidelines: Are We Pressured to Change? Oregon Cardiovascular Symposium Portland, Oregon June 6, Financial Disclosures

Treating Hypertension in Individuals with Diabetes

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials

Measure Up Pressure Down. Scott Flinn MD Fritz Steen RN

Blood Pressure LIMBO How Low To Go?

New Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids.

Placebo-Controlled Statin Trials MANAGEMENT OF HIGH BLOOD CHOLESTEROL MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES

None. Disclosure: Relationships with Industry Conflicts of Interests. Learning Objectives: Participants will be able to:

Objectives. Describe results and implications of recent landmark hypertension trials

New Hypertension Guidelines: Why the change? Neil Brummond, M.D. Avera Medical Group Internal Medicine Sioux Falls, SD

Objectives. JNC 7 Is Nice But What s Up With JNC 8? Why Do We Care? Hypertension Background: Prevalence

Lipid Management 2013 Statin Benefit Groups

Blue Shield Participation

Objective & Outline. How the JNC Process Has Evolved. Expertise Represented on JNC 8 Panel

Atherosclerotic Disease Risk Score

JNC 8 -Controversies. Sagren Naidoo Nephrologist CMJAH

Placebo-Controlled Statin Trials Prevention Of CVD in Women"

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary

Long-Term Complications of Diabetes Mellitus Macrovascular Complication

Speaker Disclosure. Pharmacist Objectives. Path to New Hypertension (HTN) Guidelines. Overview of New HTN Guidelines 8/21/2014

Controlling Hypertension in Primary Care: Hitting a moving target?

Hypertension and Cardiovascular Disease

Causes of Poor BP control Rates

No relevant financial relationships

ALLHAT RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR)

Update in Cardiology Pharmacologic Management of Cardiovascular Risk. Christopher C. Roe, MSN, ACNP

Prevention of Heart Failure: What s New with Hypertension

Hypertension. Does it Matter What Medications We Use? Nishant K. Sekaran, M.D. M.Sc. Intermountain Heart Institute

Hypertension in 2015: SPRINT-ing ahead of JNC-8. MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic

Preventing and Treating High Blood Pressure

PHASE Preventing Heart Attacks & Strokes Everyday

MODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure. No relevant financial relationships. Blood Pressure and Risk

Antihypertensive Trial Design ALLHAT

Misperceptions still exist that cardiovascular disease is not a real problem for women.

Hyperlipidemia. Intern Immersion Block 2015

Placebo-Controlled Statin Trials EXPLAINING THE DECREASE IN DEATHS FROM CHD! PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN EXPLAINING THE DECREASE IN

Hypertension and the Challenge of Adherence. Geneva Clark Briggs, Pharm.D., BCPS

CONTRIBUTING FACTORS FOR STROKE:

Patients Will Be Safe With A-L-L Heart Protection. Care Management Institute Kaiser Permanente 9/2012

HYPERTENSION: UPDATE 2018

Hypertension JNC 8 (2014)

Long-Term Care Updates

The New Hypertension Guidelines

hypertension Head of prevention and control of CVD disease office Ministry of heath

ALLHAT. Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic

Management of Hypertension. Ahmed El Hawary MD Suez Canal University

Complications of Diabetes mellitus. Dr Bill Young 16 March 2015

Update in Outpatient Medicine JNC 8, Hypertension and More

Conflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines

Hypertension Update 2016 AREEF ISHANI, MD MS CHIEF OF MEDICINE MINNEAPOLIS VA MEDICAL CENTER PROFESSOR OF MEDICINE UNIVERSITY OF MINNESOTA

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials

Hypertension: What s new since JNC 7. Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF

4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?

Hypertension Management: A Moving Target

Presentation title. Better Health Care For Greater Cleveland Learning Collaborative March 5, Ron Adams, MD Regional Chief Internal Medicine

Managing Hypertension in 2016

Int. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 06, Pages: JNC 8 versus JNC 7 Understanding the Evidences

Creative blood pressure management: whys and the tricks

Modern Management of Hypertension

Hypertension: 2016 Clinical Update

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE

ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH

4/24/15. AHA/ACC 2013 Guideline Key Points

Highlights of the new blood pressure and cholesterol guidelines: A whole new philosophy. Jeremy L. Johnson, PharmD, BCACP, CDE, BC-ADM

Management of High Blood Pressure in Adults

Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation. Hot Off the Press and into Your Practice: The Last Year in Medical News

New Antihypertensive Strategies to Improve Blood Pressure Control

Implementation of JNC- 8 Hypertension Recommendations: Combining evidence and value-based practice strategies for accountable care

The Diabetes Link to Heart Disease

Disclosures. Overview 9/30/ ACC/AHA Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

Hypertension Guidelines JNC Recommendations. Robert E. Bulow DO FACOI, FACC

Hypertension Management Controversies in the Elderly Patient

Primary Prevention of Cardiovascular Disease (CVD) Events with Statins. 1 Primary Prevention of Cardiovascular Disease (CVD) Events with Statins

Hypertension Guidelines: Lessons for Primary Care. Paul A James MD Professor and Chair Department of Family Medicine University of Washington

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005

Adult Hypertension Clinical Practice Guidelines

ADVANCES IN MANAGEMENT OF HYPERTENSION

ALLHAT. ALLHAT Antihypertensive Trial Results by Baseline Diabetic & Fasting Glucose Status

Cardiovascular Controversies: Exploring the ACC and AHA Guidelines on the Treatment of Blood Cholesterol

Cedars Sinai Diabetes. Michael A. Weber

How Low Do We Go? Update on Hypertension

Modern Management of Hypertension: Where Do We Draw the Line?

Osama Sanad (MD) Prof. of Cardiology Benha University 2016

Clinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8. Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital

Disclosures No relationships (not even to an employer) No off-label uses. Cholesterol Lowering Guidelines: What now?

Blood Pressure Acre Surgery Diviash Thakrar

CVD Outcomes Aggregate Report Report Period: 05/01/ /30/2004

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am

Managing Hypertension in Diabetes Sean Stewart, PharmD, BCPS, BCACP, CLS Internal Medicine Park Nicollet Clinic St Louis Park.

Transcription:

Best Practices in Cardiac Care: Getting with the Guidelines December 9, 2014 Agenda Cardiovascular Disease: How do the guidelines fit into an implementation scheme? What the guidelines set out to accomplish What didn t it tackle? Case Study: How to achieve 75% fewer heart attacks after the first visit Implementation in the community How can any of these ideas improve your hypertension AIM? 2 1

Kaiser Permanente s History and Mission To provide high quality affordable health care and improve the health of our members and the communities we serve. 3 Health Plan Membership* by Region Colorado: 618,802 Washington Georgia: 259,450 Hawaii: 229,746 Oregon Mid-Atlantic States: 516,099 (VA, MD, DC) Northern California Denver, Colorado Maryland Northern California: 3,579,580 Northwest: 499,011 (Oregon/Washington) Southern California: 3,762,200 Southern California Southern Colorado Washington DC Virginia Hawaii Georgia * as of June 31, 2014 4 2

Harriet Hypertensive 5 Harriet Hypertensive 55 yo Afircan American church Decons Assistant with a touch of sugar [A1Cs 6.6% & 6.7] & new repeated BP is 160/95, Last week her she had normal liver, kidney, potassium and cholesterol [165, LDL of 95] No doctor visit in over 2 yrs, (busy at work, no car, and copays are too high) She doesn t worry about BP (she feels fine) but her older brother just had a stroke, and she is worried about having one herself. What do the new HTN guidelines say to do? What is the best overall approach for Harriet? 1. Start a BP drug now? 2. Start 2 BP drugs now? 3. Given a normal cholesterol, should we advise a statin? 6 3

What s With the New CVD Prevention Guidelines? Are they evidence based? What is the ultimate aim? Do they set BP targets? Do they tell you what drugs to use? What don t they tackle that is important for implementation? 7 History of CVD Clinical Guidelines Went from Consensus NHLBI NHLBI HHS: AHQR Joint National Committee on Prevention, Detection, Evaluation, & Treatment of High Blood Pressure (JNC) JNC 7: 2003 JNC 6: 1997 JNC 5: 1992 JNC 4: 1988 JNC 3: 1984 JNC 2: 1980 JNC 1: 1976 Detection, Evaluation, & Treatment of High Blood Cholesterol in Adults (ATP, Adult Treatment Panel) ATP III Update: 2004 ATP III: 2002 ATP II: 1993 ATP I: 1988 United States Preventative Services Task Force [USPSTF] Aspirin Guidelines 2009 2004 8 4

To Being Strictly Evidence-Based Focus only on randomized controlled trials assessing important health outcomes (no use of intermediate/surrogate measures) 9 What s the JNC8 Guideline OUTCOME [AIM] 1. Get patients BP of under 140/90? 2. Get patients BP of under 150/90? 3. Decrease cardiovascular and renal disease? 4. Provide a list of drugs that are proven to lower BP? 5. To provide controversial debate for years? 10 5

And JNC 8 Used Only Hard Ultimate Outcomes [AIMS] 90% of mortality is due to CVD in hypertensive people CVD-related mortality Myocardial infarction Heart failure Stroke End Stage Renal Disease 11 2014 HTN Evidence-Based Guideline The focus is on the panel s three highest ranked questions related to HTN management: In hypertensive adults, related to health outcomes: 1. does antihypertensive drug therapy at BP thresholds improve them? 2. does antihypertensive drug therapy to a BP goal improve them? 3. do antihypertensive drugs differ in benefits and harms? 12 6

They Set BP Targets and Allow for Medication Combinations 13 Possible Initial Combinations of Medications Diuretics ACE inhibitors or ARBs Calcium antagonists 14 7

What The Guidelines Don t Do Overcome Barriers to Implementation Such As: Medical Care System Barriers: A system for practitioners to treat to target BP To consider other than BP meds to achieve the aim Making it easy for a patient to get a BP to take the drugs Personal Barriers: Inconvenience & cost I m overwhelmed with stuff. I don t have time for visits, tests, etc. I can t take off work, get transportation, copays, and costs of medications Remembering to take many pills at different times and get refills at a pharmacy 15 So where Do Guidelines Fit in Implementation? Factors of a Kaiser successful hypertension program used evidence-based guidelines hypertension registry sharing of performance metrics medical assistant visits for blood pressure measurement single-pill combination pharmacotherapy *JAMA. 2013;310(7):699-705 16 8

JAMA. 2013;310(7):699-705. 17 How Much does A Single Combination Pill Improve Adherence? >¾ of the time is good, <1/4 of the time is poor Good poor 1. 0% 20% 2. 5% 25% 3. 10% 50% 18 9

Why Combine 2 BP medications in a single pill? To improve adherence & overcome Therapeutic inertia (<85 mm Hg, diastolic) UKPDS (92 mm Hg, MAP) MDRD (<80 mm Hg, diastolic) HOT (<92 mm Hg, MAP) AASK (<140/90 mm Hg) RENAAL (<135/85 mm Hg) IDNT 1 2 3 4 Number of agents required to achieve blood pressure (BP) goal in high-risk patients with hypertension with diabetes or impaired renal function. 19 Simplicity: Single Pill Fixed Dose Combination Based SIMPLICITY = Fewer steps achieving your aim Fewer pills Faster control Fewer visits/ improved access 20 20 10

What is the Ultimate AIM? Bring High Blood Pressure to normal? NO! PREVENT HEART ATTACKS & STROKES in people with hypertension So how does BP fit into the way a heart attack or stoke is formed? What else would help? 22 11

Whats the Most Effective Number of Drugs that Can Be Started at the First Visit to prevent CVD in a Person with Hypertension? 1 2 3 4 After 8 years the committee couldn t get to that, [need more FF miles to answer] 23 Back to Basics: What Causes a Heart Attack in HTN or DM or CVD Patients Lipid Lowering Med Lisinopril [BP lowering] Aspirin PLAQUE with fibrous cap Cap ruptures cracks Blood clot forms around the rupture, blocking the artery 24 12

So Would a STATIN Help? YES If high ASCVD risk AHA/ACC Lipid guidelines: Treat ANY high CVD risk patient regardless of BP or LDL Estimate 10-y ASCVD Risk with Pooled Cohort Equations* >7.5% estimated 10-y ASCVD risk and age 40-75 y Yes Moderate-to-high intensity statin 25 Harriet s ACC/AHA CV risk score risk score 26 2014 Kaiser Foundation Health Plan, Inc. 13

While ACE/Thiazide Drops CVD a lot, Add Over 40% Reduction with just an Aspirin and statin in all high risk states 120% 100% 80% 25% 25% 60% 40% 20% 0% 22% 22% 22% 35% 35% 35% 35% 10% 10% 10% 15% CVD risk 10% >55 DM >55 HTN MI or Stroke Aspirin Lip lowering Lisip or any ACE/ARB Thiaz Beta Blocker Statins Add Significantly to A HTN Pt s CVD Prevention And are more powerful that an ACE/Thiazide combination: Doubled Quadrupled 28 14

What About Aspirin? It s Also Recommended in High CVD Risk Patients The USPSTF recommends the use of aspirin for men age 45 to 79 years [and women 55-79] when the potential benefit outweighs the potential harm* Grade: A recommendation. * for most people it s the same 7.5% CVD risk level for starting a statin 29 You Can Decrease Heart Attacks, Strokes or Death from them [MACE]* ~75% with just 4 pills/d 30 * Population: SBP >140 & age>55yo Major Adverse Coronary Events 15

What s the Most Important Factor When Implementing 4 drugs? Simplicity! The better path is to make the target behavior easier to do. - Six Principles of Simplicity, BJ Fogg 31 How Can We Do It Simply? Bundle Up! JNC8 Hypertension AHA/ACC Dyslipidemia USPSTF aspirin guidelines First visit BUNDLE if High CVD risk 32 16

Summary: For 75% decrease in MI s & strokes, on the First Visit, simply think : TALL Thiazide-ACE* Aspirin Lipid Lowering statin 33 Harriet Hypertensive 55 yo housekeeper with a touch of sugar [A1Cs 6.6% & 6.7] & new repeated BP is 160/95, Last week her she had normal liver, kidney, potassium and LDL cholesterol [95 mg%] tests No doctor visit in over 2 yrs, cant get off work, no car, and copays are too high. She doesn t worry about BP but her older brother just had a stroke, and she is worried about having one herself. What do the new HTN guidelines say to do? What is the best overall approach for Harriet? 1. Start a BP drug now? 2. Start 2 BP drugs now? 1. Given a normal cholesterol, should we advise a statin? 34 17

35 5 Yrs later, looking GREAT! It s All About Implementation It has to work in the real world! 36 18

Implementing TALL in the Community Simplified Treatment Algorithm + Culture Change + Patient Engagement = 37 Provider Communities: Creating a Culture of Quality Improvement & Accountability Annual Quality Goal Targets Un-blinded Medical Center Performance Reports Central Hypertension Management Team identified Best Practices Medical Center Cardiovascular Risk Reduction Teams to Support Physicians Best Practices Disseminated through Regional Peer Meetings Clinic-level feedback to facilitate operational and system-level change 38 19

Engaging Patients & Their Families Where they Live, Work, Play and Pray I ve had high blood pressure since my 40s. I used to stop at pharmacies and stick my arm in the machines, but I just don t see how they can be accurate. Having my pressure measured on a regular basis at Wally s keeps the information steady and has made me think more seriously about it. 39 Public Policy Implications 40 20

Workshop: Take 15 min at your table to design into your routine BP care scheme any of the above ideas that you wish and report out: How much will YOUR NEW` AIM reduce heart attacks & strokes? Will it be simpler, the same, or more complex than your present system? What is one next step you will take to make that happen? 41 21